Atlas Trials

Analysis of Re-biopsy Specimens in Advanced NSCLC With Acquired Resistance of EGFR-TKI Targeted Therapy

Clinical trial NCT03309462 · COMPLETED

Trial details

NCT number
NCT03309462
Sponsor
Shanghai Chest Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Lung Cancer
Start date
2017-09-01
Primary completion
2018-06-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.